FREE UK SHIPPING ORDER BY 12:00 · SAME-DAY DISPATCH 20% FIRST REGISTERED ORDER 10% RETURNING CUSTOMER PRICING LIVE STOCK & PRICING SECURE STRIPE CHECKOUT RESEARCH USE ONLY DIRECT UK SUPPORT FREE UK SHIPPING ORDER BY 12:00 · SAME-DAY DISPATCH 20% FIRST REGISTERED ORDER 10% RETURNING CUSTOMER PRICING LIVE STOCK & PRICING SECURE STRIPE CHECKOUT RESEARCH USE ONLY DIRECT UK SUPPORT
SLSYNTRALABS
SYNTRA LABSFree UK shipping · 12:00 dispatch cutoff
FREE UK SHIPPINGAfter 12:00 · next working-day dispatchCutoff 12:00 UK
METABOLICSL-SURVO10
CURRENT OFFER30% OFF
Survodutide 10 mg
CATALOGUE IMAGEResearch-use presentation
Home/Catalogue/SURVO10
Metabolic · SURVO10

Survodutide

10 mg

Dual glucagon / GLP-1 receptor agonist. Presented as a catalogue material for controlled laboratory research workflows.

0110 mg vial02Metabolic research03Limited stock
CURRENT OFFER
£45.50£65.00
Save £19.50 · 30%
8 in stockLimited availability in the current catalogue batch
Server-verified priceSecure Stripe checkoutLive catalogue stockUK support
EVIDENCE ORIENTATIONClinical literature

The molecule is of research interest because it combines incretin signalling with glucagon-receptor biology in one investigational scaffold.

RESEARCH DOSSIER · SL-SURVO10

Survodutide: compound context & catalogue record.

Compound-level literature, catalogue specifications and availability are deliberately separated so scientific context is not confused with product validation.

Clinical literature
CATALOGUE IDSL-SURVO10Metabolic
PRESENTATION10 mgResearch vial
FOCUS AREAS3Mapped themes
REFERENCES1Selected literature
COMPOUND CLASS

Dual glucagon / GLP-1 receptor agonist

An investigational dual agonist combining glucagon-receptor and GLP-1-receptor activity.

EVIDENCE SUMMARY

Clinical literature

A 48-week randomized phase 2 trial studied survodutide in metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis. This is compound-level scientific context only and is not a therapeutic claim for catalogue material.

INTERPRETATION

The molecule is of research interest because it combines incretin signalling with glucagon-receptor biology in one investigational scaffold.

Research-use information only.No section of this dossier provides medical advice, dosing, administration instructions or veterinary guidance; selected references describe the named compound or pathway and do not independently validate this catalogue item.
RELATED CATALOGUE MATERIALS

Continue within this research category.

Full catalogue →
10 mg£45.50
Survodutide 10 mg | Syntra Labs